162 related articles for article (PubMed ID: 8590544)
1. Monoclonal antibodies recognising sialyl-Tn: production and application to immunochemistry.
Devine PL; Birrell GW; Quin RJ; Shield PW
Dis Markers; 1995 Aug; 12(3):175-86. PubMed ID: 8590544
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy.
Siddiki B; Ho JJ; Huang J; Byrd JC; Lau E; Yuan M; Kim YS
Int J Cancer; 1993 May; 54(3):467-74. PubMed ID: 7685327
[TBL] [Abstract][Full Text] [Related]
4. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity.
Toba S; Tenno M; Kurosaka A
Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288
[TBL] [Abstract][Full Text] [Related]
5. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
[TBL] [Abstract][Full Text] [Related]
6. Analysis of monoclonal antibodies reactive with meconium- and amniotic fluid-derived mucin.
Kobayashi H; Ohi H; Terao T
J Clin Lab Anal; 1994; 8(1):27-34. PubMed ID: 8164108
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody recognizing a core epitope on mucin.
Devine PL; Quin RJ; Shield PW; Liew YW; Sheehan JK; Thornton DJ
Dis Markers; 1998 Oct; 14(2):99-112. PubMed ID: 9868597
[TBL] [Abstract][Full Text] [Related]
8. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
[TBL] [Abstract][Full Text] [Related]
9. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
[TBL] [Abstract][Full Text] [Related]
10. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
O'Boyle KP; Wright K
Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
[TBL] [Abstract][Full Text] [Related]
11. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies reacting with the MUC2 mucin core protein.
Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
[TBL] [Abstract][Full Text] [Related]
13. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
[TBL] [Abstract][Full Text] [Related]
14. Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model.
O'Boyle KP; Goya V; Zuckier LS; Chun S; Bhargava K
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):251-61. PubMed ID: 7533599
[TBL] [Abstract][Full Text] [Related]
15. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes.
Reddish MA; Jackson L; Koganty RR; Qiu D; Hong W; Longenecker BM
Glycoconj J; 1997 Aug; 14(5):549-60. PubMed ID: 9298687
[TBL] [Abstract][Full Text] [Related]
16. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH
Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as adjuvants: effect on the immunogenicity of NeuAc alpha 2-6GalNAc alpha-O-Ser/Thr (sialyl-Tn).
Piera M; de Bolós C; Castro R; Real FX
Int J Cancer; 1993 Aug; 55(1):148-52. PubMed ID: 8344745
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.
Huang J; Byrd JC; Siddiki B; Yuan M; Lau E; Kim YS
Dis Markers; 1992; 10(2):81-94. PubMed ID: 1281060
[TBL] [Abstract][Full Text] [Related]
19. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.
Ogata S; Koganty R; Reddish M; Longenecker BM; Chen A; Perez C; Itzkowitz SH
Glycoconj J; 1998 Jan; 15(1):29-35. PubMed ID: 9530954
[TBL] [Abstract][Full Text] [Related]
20. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO
Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
